FDA Granted Orphan Drug Designation to IMP4297+TMZ for SCLC
August 19, 2022 05:00 ET
|
IMPACT Therapeutics
SHANGHAI, China, Aug. 19, 2022 (GLOBE NEWSWIRE) -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic...